Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial

Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial

Abstract Background Transarterial chemoembolization (TACE) is commonly used to treat patients with unresectable hepatocellular carcinoma (HCC); however, TACE alone has demonstrated unsatisfactory survival benefits. Our previous studies suggested that TACE plus oral medication of thalidomide, carmofu...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Li, Bei Lv, Li Song, Xingxing Zhang, Jian Zhang, Xiaoyi Ding, Yongqiang Liu, Tao Ye, Mengzhou Guo, Tingting Fang, Biwei Yang, Zhiying Zhao, Peixin Huang, Yi Chen, Ningling Ge, Jinglin Xia
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Translational Medicine
Subjects:
Transarterial chemoembolization
Hepatocellular carcinoma
Combination therapy
Thalidomide
Online Access:https://doi.org/10.1186/s12967-025-06624-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12967-025-06624-x

Similar Items